ࡱ> :9 \p ktzovelekis Ba= =xKL;$8X@"1Arial1Arial1Arial1Arial1 Arial1Arial1Verdana1Verdana"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)3#,##0\ " ";\-#,##0\ " "=#,##0\ " ";[Red]\-#,##0\ " "?#,##0.00\ " ";\-#,##0.00\ " "I"#,##0.00\ " ";[Red]\-#,##0.00\ " "q6_-* #,##0\ " "_-;\-* #,##0\ " "_-;_-* "-"\ " "_-;_-@_-k3_-* #,##0\ _ _-;\-* #,##0\ _ _-;_-* "-"\ _ _-;_-@_->_-* #,##0.00\ " "_-;\-* #,##0.00\ " "_-;_-* "-"??\ " "_-;_-@_-{;_-* #,##0.00\ _ _-;\-* #,##0.00\ _ _-;_-* "-"??\ _ _-;_-@_-![$-408]dddd\,\ d\ mmmm\ yyyy d/m/yyyy;@"Yes";"Yes";"No""True";"True";"False""On";"On";"Off"],[$ -2]\ #,##0.00_);[Red]\([$ -2]\ #,##0.00\) d/m/yy;@                      "x@ @  "|@ @     "|@ @       A A  "|@ @     1 `Aug2008%Sep2008..Oct2008F>Nov2008iGDec2008";F-TitleDateURLSourceSummarynA Company and Industry Analysis of North America's Biotechnology Sectors: Understand the Regulatory Environmen Business Wire~Research and Markets has announced the addition of the 'North America Biotechnology Sectors: A Company and Industry Analysis & ;http://c.moreover.com/click/here.pl?z1638474170&z=950242273Zeus VP named to biotech panelOrangeburg Times DemocraRobert Ballard, vice president of research and the strategic business department at Zeus Inc., has been appointed to serve on the South Carolina Biotechnology Incubation Program Board of Governors.Ballard was appointed to serve on the& ;http://c.moreover.com/click/here.pl?z1639534200&z=9502422731 BIO-Europe 2008 Announces New Program HighlightsOnly a month remains before BIO-Europe 2008, the worlds largest stand-alone partnering conference, takes place in Mannheim/Heidelberg, Germany, November 17-19. 14/10/2008;http://c.moreover.com/click/here.pl?z1643931142&z=950242273;Pharmaceutical Research Council mooted under dept of pharmayA proposal has been mooted to create a Pharmaceutical Research Council on the lines of Indian Council of Medical Research PharmaBizPhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45510§ionid=20Phttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45491§ionid=19LUS FDA commences surprise re-inspections of all approved facilities in IndiaUS FDA has commenced surprise inspections of all its approved facilities in India as a fallout of the recent allegations of exporting substandard drugs by Ranbaxy Labs.@CII study predicts 19% growth for Indian pharma industry by 20152/9/2008Riding on different factors from expansion of middle class, generic and brand development, marketing effectiveness, rural markets and health insurance, the Indian pharmaceutical industry will grow at 19.64 per cent by 2015 PharmabizOhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45903§ionid=5IPharma Dept prepares scheme to set up generic drug store in each district1/9/2008The Department of Pharmaceuticals has drawn up a scheme to set up generic drug stores in each district of the country to ensure affordable medicines to the poor sections of the society.Phttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45887§ionid=19IUS FDA grants nod for 75th generic anti-retroviral drug as part of PEPFARThe Food and Drug Administration within the US Department of Health and Human Services (HHS) has reached the milestone of the 75th anti-retroviral generic drugPhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=46767§ionid=14@BMS Foundation to award $1.4 mn in grants for hep C care in AsiaBristol-Myers Squibb Company (BMS) and the Bristol-Myers Squibb Foundation announced plans to award $1.4 million in grants focused on hepatitis C prevention and educationOhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=46806§ionid=6OSPIC urges Centre to help SME sector with liberal funds to grab generics marketSME Pharma Industries Confederation (India) (SPIC) has urged the government to extend liberal funds to the small and medium sector to upgrade itself to the world class standards with a view to exploit the emerging global scenarioOhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=47195§ionid=5;Indian API exports to grow nearly three fold in 2012: StudyThe exports of active pharmaceutical ingredients from India is expected to record huge growth in the coming years especially by leveraging the growing generics market in US, Europe and Japan, says business consultants.Phttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=47233§ionid=112 = +Uo  ccj  !  dMbP?_*+%"??U} } } } &} !}             ~  ^@    ~ ^@        @RDPFF >@  7|yK Qhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45510&sectionid=20yK http://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45510&sectionid=20|yK Qhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45491&sectionid=19yK http://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45491&sectionid=19  %*  dMbP?_*+%"F??QU} F} F} "F} &F} !F} F              #    #   ## #### ! ! !  BhXPF8 >@  7xyK Phttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45903&sectionid=5yK http://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45903&sectionid=5|yK Qhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45887&sectionid=19yK http://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45887&sectionid=19   5E:  dMbP?_*+%M2Canon PIXMA iP1500 T߁ 4dA4TBJDM ,Rt,T`Op,T`OpRt,TT`Op,TT,TT`OpXX 1' d Rt Rt@ RtCanon PIXMA iP1500 T߁ 4dA4U7" d??U} } } } &} !}  Date            ~ `f@     ~ @j@            BXPFF8 >@  7(yK <http://c.moreover.com/click/here.pl?z1638474170&z=950242273yK xhttp://c.moreover.com/click/here.pl?z1638474170&z=950242273(yK <http://c.moreover.com/click/here.pl?z1639534200&z=950242273yK xhttp://c.moreover.com/click/here.pl?z1639534200&z=950242273(yK <http://c.moreover.com/click/here.pl?z1643931142&z=950242273yK xhttp://c.moreover.com/click/here.pl?z1643931142&z=950242273  ?C  dMbP?_*+%"F??<U} F} F} F} &F} !F} F           ! ~  i@ " # $ ~ i@ % &       BvXPFF >@7|yK Qhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=46767&sectionid=14yK http://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=46767&sectionid=14xyK Phttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=46806&sectionid=6yK http://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=46806&sectionid=6  %HM  dMbP?_*+%"F??PU} F} F} F} &F} !F} F           ' ~ l@ ( ) * ~ m@ + ,       BvXPFF >@  7xyK Phttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=47195&sectionid=5yK http://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=47195&sectionid=5|yK Qhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=47233&sectionid=11yK http://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=47233&sectionid=11 Oh+'0@Hp  Χρήστος ΚενούτηςOuraniaMicrosoft Excel@` m@q՜.+,D՜.+,@ PXl t|  Οικία Aug2008Sep2008Oct2008Nov2008Dec2008  Worksheets  8@ _PID_HLINKSABFQhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45491&sectionid=19GQhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45510&sectionid=20GQhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45887&sectionid=19+vPhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=45903&sectionid=5$|<http://c.moreover.com/click/here.pl?z1643931142&z=950242273/v<http://c.moreover.com/click/here.pl?z1639534200&z=950242273)p<http://c.moreover.com/click/here.pl?z1638474170&z=950242273/uPhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=46806&sectionid=6GQhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=46767&sectionid=14FQhttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=47233&sectionid=11%}Phttp://www.pharmabiz.com/article/detnews.asp?Arch=a&articleid=47195&sectionid=5  !"#$%&'(*+,-./02345678Root Entry FBҎ-vWorkbookPSummaryInformation()DocumentSummaryInformation81